Review



non targeting nt control sgrna  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Addgene inc non targeting nt control sgrna
    Non Targeting Nt Control Sgrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 5733 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting nt control sgrna/product/Addgene inc
    Average 96 stars, based on 5733 article reviews
    non targeting nt control sgrna - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    sgrna/cas9 all-in-one expression clones targeting zdhhc7  (Genecopoeia)
    94
    Genecopoeia sgrna/cas9 all-in-one expression clones targeting zdhhc7
    Sgrna/Cas9 All In One Expression Clones Targeting Zdhhc7, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sgrna/cas9 all-in-one expression clones targeting zdhhc7/product/Genecopoeia
    Average 94 stars, based on 1 article reviews
    sgrna/cas9 all-in-one expression clones targeting zdhhc7 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    sgrna/cas9 all-in-one expression clones targeting kras  (Genecopoeia)
    94
    Genecopoeia sgrna/cas9 all-in-one expression clones targeting kras
    Sgrna/Cas9 All In One Expression Clones Targeting Kras, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sgrna/cas9 all-in-one expression clones targeting kras/product/Genecopoeia
    Average 94 stars, based on 1 article reviews
    sgrna/cas9 all-in-one expression clones targeting kras - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    non targeting nt control sgrna  (Addgene inc)
    96
    Addgene inc non targeting nt control sgrna
    Non Targeting Nt Control Sgrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting nt control sgrna/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    non targeting nt control sgrna - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    target sgrnas  (Addgene inc)
    98
    Addgene inc target sgrnas
    Target Sgrnas, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/target sgrnas/product/Addgene inc
    Average 98 stars, based on 1 article reviews
    target sgrnas - by Bioz Stars, 2026-05
    98/100 stars
    		  Buy from Supplier
    sgrnas targeting adam10  (Addgene inc)
    94
    Addgene inc sgrnas targeting adam10
    A , Schematic of the CRISPR-Cas9 screen. B , Volcano plot of genes from the screen, ranked by fold change and adjusted P value. C , Representative flow cytometry dot plots of GW01-induced syncytia between A549-spike and FCER1G -KO (FcRγ-KO) THP-1 clones versus non-targeting control (NT), and quantification of syncytia(right inset)(mean ± SEM, n=3, * P <0.05, **** P <0.0001). D , Representative plots A549-spike fusion with <t>ADAM10-KO</t> THP-1 clones versus control and quantification of syncytia. E , Rescue of FcRγ: representative plots for FcRγ-KO-LVX (empty lentiviral vector), FcRγ-KO-FcRγ (FcRγ cDNA), and NT-LVX; with quantification of syncythia. F , Rescue of ADAM10: representative plots for ADAM10-KO-LVX (empty vector), ADAM10-KO-ADAM10 (ADAM10 cDNA), and NT-LVX, along with quantification of syncytia. G , Effect of CD64 or CD32 blocking antibodies on GW01-dependent syncytium formation measured by NanoLuc assay. H , Effect of the ADAM10 inhibitor GI254023X on GW01-dependent syncytium formation. I , Representative fluorescence images of syncytia (yellow merge) between THP-1-mCherry (red) and A549-spike (green; CFSE) at 3 hour post co-culture, with or without GI254023X. Scale bar, 100 μm. Data are presented as mean ± SEM, n=3, * P <0.05, *** P <0.001, **** P <0.0001 by one-way ANOVA.
    Sgrnas Targeting Adam10, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sgrnas targeting adam10/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    sgrnas targeting adam10 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    s c r ip t target gene specific crispr cas9 expression clones  (Genecopoeia)
    94
    Genecopoeia s c r ip t target gene specific crispr cas9 expression clones
    A , Schematic of the CRISPR-Cas9 screen. B , Volcano plot of genes from the screen, ranked by fold change and adjusted P value. C , Representative flow cytometry dot plots of GW01-induced syncytia between A549-spike and FCER1G -KO (FcRγ-KO) THP-1 clones versus non-targeting control (NT), and quantification of syncytia(right inset)(mean ± SEM, n=3, * P <0.05, **** P <0.0001). D , Representative plots A549-spike fusion with <t>ADAM10-KO</t> THP-1 clones versus control and quantification of syncytia. E , Rescue of FcRγ: representative plots for FcRγ-KO-LVX (empty lentiviral vector), FcRγ-KO-FcRγ (FcRγ cDNA), and NT-LVX; with quantification of syncythia. F , Rescue of ADAM10: representative plots for ADAM10-KO-LVX (empty vector), ADAM10-KO-ADAM10 (ADAM10 cDNA), and NT-LVX, along with quantification of syncytia. G , Effect of CD64 or CD32 blocking antibodies on GW01-dependent syncytium formation measured by NanoLuc assay. H , Effect of the ADAM10 inhibitor GI254023X on GW01-dependent syncytium formation. I , Representative fluorescence images of syncytia (yellow merge) between THP-1-mCherry (red) and A549-spike (green; CFSE) at 3 hour post co-culture, with or without GI254023X. Scale bar, 100 μm. Data are presented as mean ± SEM, n=3, * P <0.05, *** P <0.001, **** P <0.0001 by one-way ANOVA.
    S C R Ip T Target Gene Specific Crispr Cas9 Expression Clones, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s c r ip t target gene specific crispr cas9 expression clones/product/Genecopoeia
    Average 94 stars, based on 1 article reviews
    s c r ip t target gene specific crispr cas9 expression clones - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    sgrna targeting msh6  (Addgene inc)
    94
    Addgene inc sgrna targeting msh6
    A , Schematic of the CRISPR-Cas9 screen. B , Volcano plot of genes from the screen, ranked by fold change and adjusted P value. C , Representative flow cytometry dot plots of GW01-induced syncytia between A549-spike and FCER1G -KO (FcRγ-KO) THP-1 clones versus non-targeting control (NT), and quantification of syncytia(right inset)(mean ± SEM, n=3, * P <0.05, **** P <0.0001). D , Representative plots A549-spike fusion with <t>ADAM10-KO</t> THP-1 clones versus control and quantification of syncytia. E , Rescue of FcRγ: representative plots for FcRγ-KO-LVX (empty lentiviral vector), FcRγ-KO-FcRγ (FcRγ cDNA), and NT-LVX; with quantification of syncythia. F , Rescue of ADAM10: representative plots for ADAM10-KO-LVX (empty vector), ADAM10-KO-ADAM10 (ADAM10 cDNA), and NT-LVX, along with quantification of syncytia. G , Effect of CD64 or CD32 blocking antibodies on GW01-dependent syncytium formation measured by NanoLuc assay. H , Effect of the ADAM10 inhibitor GI254023X on GW01-dependent syncytium formation. I , Representative fluorescence images of syncytia (yellow merge) between THP-1-mCherry (red) and A549-spike (green; CFSE) at 3 hour post co-culture, with or without GI254023X. Scale bar, 100 μm. Data are presented as mean ± SEM, n=3, * P <0.05, *** P <0.001, **** P <0.0001 by one-way ANOVA.
    Sgrna Targeting Msh6, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sgrna targeting msh6/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    sgrna targeting msh6 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    plg1 puro non targeting sgrna 3  (Addgene inc)
    93
    Addgene inc plg1 puro non targeting sgrna 3
    A , Schematic of the CRISPR-Cas9 screen. B , Volcano plot of genes from the screen, ranked by fold change and adjusted P value. C , Representative flow cytometry dot plots of GW01-induced syncytia between A549-spike and FCER1G -KO (FcRγ-KO) THP-1 clones versus non-targeting control (NT), and quantification of syncytia(right inset)(mean ± SEM, n=3, * P <0.05, **** P <0.0001). D , Representative plots A549-spike fusion with <t>ADAM10-KO</t> THP-1 clones versus control and quantification of syncytia. E , Rescue of FcRγ: representative plots for FcRγ-KO-LVX (empty lentiviral vector), FcRγ-KO-FcRγ (FcRγ cDNA), and NT-LVX; with quantification of syncythia. F , Rescue of ADAM10: representative plots for ADAM10-KO-LVX (empty vector), ADAM10-KO-ADAM10 (ADAM10 cDNA), and NT-LVX, along with quantification of syncytia. G , Effect of CD64 or CD32 blocking antibodies on GW01-dependent syncytium formation measured by NanoLuc assay. H , Effect of the ADAM10 inhibitor GI254023X on GW01-dependent syncytium formation. I , Representative fluorescence images of syncytia (yellow merge) between THP-1-mCherry (red) and A549-spike (green; CFSE) at 3 hour post co-culture, with or without GI254023X. Scale bar, 100 μm. Data are presented as mean ± SEM, n=3, * P <0.05, *** P <0.001, **** P <0.0001 by one-way ANOVA.
    Plg1 Puro Non Targeting Sgrna 3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plg1 puro non targeting sgrna 3/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    plg1 puro non targeting sgrna 3 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    plenticrisprv2  (Addgene inc)
    93
    Addgene inc plenticrisprv2
    A , Schematic of the CRISPR-Cas9 screen. B , Volcano plot of genes from the screen, ranked by fold change and adjusted P value. C , Representative flow cytometry dot plots of GW01-induced syncytia between A549-spike and FCER1G -KO (FcRγ-KO) THP-1 clones versus non-targeting control (NT), and quantification of syncytia(right inset)(mean ± SEM, n=3, * P <0.05, **** P <0.0001). D , Representative plots A549-spike fusion with <t>ADAM10-KO</t> THP-1 clones versus control and quantification of syncytia. E , Rescue of FcRγ: representative plots for FcRγ-KO-LVX (empty lentiviral vector), FcRγ-KO-FcRγ (FcRγ cDNA), and NT-LVX; with quantification of syncythia. F , Rescue of ADAM10: representative plots for ADAM10-KO-LVX (empty vector), ADAM10-KO-ADAM10 (ADAM10 cDNA), and NT-LVX, along with quantification of syncytia. G , Effect of CD64 or CD32 blocking antibodies on GW01-dependent syncytium formation measured by NanoLuc assay. H , Effect of the ADAM10 inhibitor GI254023X on GW01-dependent syncytium formation. I , Representative fluorescence images of syncytia (yellow merge) between THP-1-mCherry (red) and A549-spike (green; CFSE) at 3 hour post co-culture, with or without GI254023X. Scale bar, 100 μm. Data are presented as mean ± SEM, n=3, * P <0.05, *** P <0.001, **** P <0.0001 by one-way ANOVA.
    Plenticrisprv2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plenticrisprv2/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    plenticrisprv2 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    A , Schematic of the CRISPR-Cas9 screen. B , Volcano plot of genes from the screen, ranked by fold change and adjusted P value. C , Representative flow cytometry dot plots of GW01-induced syncytia between A549-spike and FCER1G -KO (FcRγ-KO) THP-1 clones versus non-targeting control (NT), and quantification of syncytia(right inset)(mean ± SEM, n=3, * P <0.05, **** P <0.0001). D , Representative plots A549-spike fusion with ADAM10-KO THP-1 clones versus control and quantification of syncytia. E , Rescue of FcRγ: representative plots for FcRγ-KO-LVX (empty lentiviral vector), FcRγ-KO-FcRγ (FcRγ cDNA), and NT-LVX; with quantification of syncythia. F , Rescue of ADAM10: representative plots for ADAM10-KO-LVX (empty vector), ADAM10-KO-ADAM10 (ADAM10 cDNA), and NT-LVX, along with quantification of syncytia. G , Effect of CD64 or CD32 blocking antibodies on GW01-dependent syncytium formation measured by NanoLuc assay. H , Effect of the ADAM10 inhibitor GI254023X on GW01-dependent syncytium formation. I , Representative fluorescence images of syncytia (yellow merge) between THP-1-mCherry (red) and A549-spike (green; CFSE) at 3 hour post co-culture, with or without GI254023X. Scale bar, 100 μm. Data are presented as mean ± SEM, n=3, * P <0.05, *** P <0.001, **** P <0.0001 by one-way ANOVA.

    Journal: bioRxiv

    Article Title: Antibody-Dependent Heterotypic Syncytia Drive COVID-19 Inflammation and Disease Progression

    doi: 10.64898/2026.02.11.705426

    Figure Lengend Snippet: A , Schematic of the CRISPR-Cas9 screen. B , Volcano plot of genes from the screen, ranked by fold change and adjusted P value. C , Representative flow cytometry dot plots of GW01-induced syncytia between A549-spike and FCER1G -KO (FcRγ-KO) THP-1 clones versus non-targeting control (NT), and quantification of syncytia(right inset)(mean ± SEM, n=3, * P <0.05, **** P <0.0001). D , Representative plots A549-spike fusion with ADAM10-KO THP-1 clones versus control and quantification of syncytia. E , Rescue of FcRγ: representative plots for FcRγ-KO-LVX (empty lentiviral vector), FcRγ-KO-FcRγ (FcRγ cDNA), and NT-LVX; with quantification of syncythia. F , Rescue of ADAM10: representative plots for ADAM10-KO-LVX (empty vector), ADAM10-KO-ADAM10 (ADAM10 cDNA), and NT-LVX, along with quantification of syncytia. G , Effect of CD64 or CD32 blocking antibodies on GW01-dependent syncytium formation measured by NanoLuc assay. H , Effect of the ADAM10 inhibitor GI254023X on GW01-dependent syncytium formation. I , Representative fluorescence images of syncytia (yellow merge) between THP-1-mCherry (red) and A549-spike (green; CFSE) at 3 hour post co-culture, with or without GI254023X. Scale bar, 100 μm. Data are presented as mean ± SEM, n=3, * P <0.05, *** P <0.001, **** P <0.0001 by one-way ANOVA.

    Article Snippet: sgRNAs targeting ADAM10 and FCER1G were cloned into pMCB320 (Addgene, 89359) and used to transduce THP-1-Cas9 cells (third-generation packaging).

    Techniques: CRISPR, Flow Cytometry, Clone Assay, Control, Plasmid Preparation, Blocking Assay, Fluorescence, Co-Culture Assay

    A , Representative flow cytometry plots showing effect of GI254023X (ADAM10 inhibitor) on GW01-dependent infection of THP-1. Histogram (right) shows effect of GI254023X concentration on SARS-CoV-2 infection of THP-1. B , Representative flow cytometry dot plots showing effect of knockout of ADAM10 or FcRγ of THP-1 on GW01-dependent direct infection of THP-1. C , Representative flow cytometry plots showing effect of indicated dose of camostat, hydroxychloroquine (HCQ), and E64d on GW01-dependent infection of THP-1. D , Dose-dependent effect of camostat, hydroxychloroquine (HCQ), and E64d on GW01-dependent SARS-CoV-2 infection of THP-1 (mean ± SEM, n=3, **** P <0.0001, compared with camostat group of same dose, by two-way ANOVA).

    Journal: bioRxiv

    Article Title: Antibody-Dependent Heterotypic Syncytia Drive COVID-19 Inflammation and Disease Progression

    doi: 10.64898/2026.02.11.705426

    Figure Lengend Snippet: A , Representative flow cytometry plots showing effect of GI254023X (ADAM10 inhibitor) on GW01-dependent infection of THP-1. Histogram (right) shows effect of GI254023X concentration on SARS-CoV-2 infection of THP-1. B , Representative flow cytometry dot plots showing effect of knockout of ADAM10 or FcRγ of THP-1 on GW01-dependent direct infection of THP-1. C , Representative flow cytometry plots showing effect of indicated dose of camostat, hydroxychloroquine (HCQ), and E64d on GW01-dependent infection of THP-1. D , Dose-dependent effect of camostat, hydroxychloroquine (HCQ), and E64d on GW01-dependent SARS-CoV-2 infection of THP-1 (mean ± SEM, n=3, **** P <0.0001, compared with camostat group of same dose, by two-way ANOVA).

    Article Snippet: sgRNAs targeting ADAM10 and FCER1G were cloned into pMCB320 (Addgene, 89359) and used to transduce THP-1-Cas9 cells (third-generation packaging).

    Techniques: Flow Cytometry, Infection, Concentration Assay, Knock-Out

    A , scRNA-seq clustering of postmortem lung tissue from patients with COVID-19. B , SARS-CoV-2 RNA expression across clusters. C , Heatmap of SARS-CoV-2 gene expression and cluster marker genes for each population. D , Expression of CD163, FCER1G , and ADAM10 . E , Heatmap of pathway enrichment in each cell population. F , ADAM10 expression in indicated cell types across clinical severity groups. G , Correlation of ADAM10 with IL6, IL1B , and TNF expression in doublets from postmortem COVID-19 lung tissue.

    Journal: bioRxiv

    Article Title: Antibody-Dependent Heterotypic Syncytia Drive COVID-19 Inflammation and Disease Progression

    doi: 10.64898/2026.02.11.705426

    Figure Lengend Snippet: A , scRNA-seq clustering of postmortem lung tissue from patients with COVID-19. B , SARS-CoV-2 RNA expression across clusters. C , Heatmap of SARS-CoV-2 gene expression and cluster marker genes for each population. D , Expression of CD163, FCER1G , and ADAM10 . E , Heatmap of pathway enrichment in each cell population. F , ADAM10 expression in indicated cell types across clinical severity groups. G , Correlation of ADAM10 with IL6, IL1B , and TNF expression in doublets from postmortem COVID-19 lung tissue.

    Article Snippet: sgRNAs targeting ADAM10 and FCER1G were cloned into pMCB320 (Addgene, 89359) and used to transduce THP-1-Cas9 cells (third-generation packaging).

    Techniques: RNA Expression, Gene Expression, Marker, Expressing